How should I manage a 73-year-old woman on valsartan/hydrochlorothiazide 320 mg/12.5 mg daily and furosemide 40 mg twice daily who now has a blood pressure of 180‑190/100 mmHg, higher than her baseline?

Immediate Intensification of Antihypertensive Therapy Required

This patient requires urgent escalation of her antihypertensive regimen with addition of a fourth agent, specifically spironolactone 25 mg daily, after confirming medication adherence and excluding secondary causes of hypertension. 1, 2

Initial Assessment Steps

Before adding medications, rapidly evaluate:

• Medication adherence: Confirm she is actually taking valsartan/HCTZ 320/12.5 mg and furosemide 40 mg BID
• Over-the-counter medications: NSAIDs, decongestants, or other BP-raising agents 1
• Volume status: Is she volume overloaded requiring diuretic adjustment?
• Secondary hypertension screening: Primary aldosteronism, renal artery stenosis, or sleep apnea are more common in resistant hypertension 1, 3

Medication Optimization Strategy

Step 1: Optimize Current Diuretic Therapy

Consider switching hydrochlorothiazide to chlorthalidone 1, 3. The current HCTZ 12.5 mg is relatively weak. Chlorthalidone provides superior 24-hour BP control and greater cardiovascular protection. However, given she's already on furosemide 40 mg BID (suggesting possible heart failure or volume overload), assess whether:

• She has heart failure: If yes, continue furosemide but ensure adequate dosing 4, 5
• She has preserved renal function (eGFR >40 mL/min): If yes, chlorthalidone 12.5-25 mg daily may be added or substituted 1
• She has reduced renal function (eGFR <40 mL/min): Thiazides lose efficacy; optimize loop diuretic dosing instead 3

Critical caveat: The combination of valsartan/HCTZ 320/12.5 mg represents near-maximal dosing of the ARB component, but the HCTZ dose is suboptimal 6.

Step 2: Add Fourth-Line Agent - Mineralocorticoid Receptor Antagonist

Spironolactone 25-50 mg daily is the preferred fourth agent 1, 2. This recommendation is based on:

• Superior BP reduction (6.6-8.7 mmHg systolic) compared to other fourth-line options in resistant hypertension 1
• Greater efficacy than doxazosin or bisoprolol in head-to-head trials 1

Monitoring requirements:

• Check serum potassium and creatinine within 5-7 days, then every 5-7 days until stable 7
• Hold if potassium ≥5.5 mmol/L or creatinine doubles 8
• Watch for gynecomastia (can substitute eplerenone 50-200 mg if this occurs, though eplerenone may require twice-daily dosing) 2

Contraindications to spironolactone:

• eGFR <45 mL/min/1.73 m² (relative contraindication) 1
• Baseline hyperkalemia
• Severe renal impairment

Step 3: Alternative Fourth-Line Options

If spironolactone is contraindicated or not tolerated:

1. Eplerenone 50-100 mg daily (may need 50-200 mg for BP effect; consider BID dosing) 2
2. Vasodilating beta-blocker (carvedilol, labetalol, or nebivolol) if not already indicated 2
3. Hydralazine or alpha-blockers only after above options exhausted 2

Special Considerations for This 73-Year-Old Patient

Heart Failure Concerns

The combination of valsartan/HCTZ plus furosemide 40 mg BID suggests possible:

• Heart failure with reduced ejection fraction: If present, this changes management significantly 9, 5
  • Target BP should be <130/80 mmHg (consider <120/80 mmHg) 5
  • Ensure she's on guideline-directed medical therapy: beta-blocker (carvedilol, metoprolol succinate, or bisoprolol), aldosterone antagonist already indicated 5
  • Spironolactone 25 mg would serve dual purpose (BP control + HF mortality benefit) 5

Renal Function Considerations

• If eGFR <40 mL/min/1.73 m²: Thiazides become ineffective; rely on loop diuretics 3
• Furosemide 40 mg BID may be inadequate if volume overloaded; can increase to 80 mg BID or higher 10
• Loop diuretics are less effective than thiazides for BP control but necessary for volume management in renal impairment 5

Practical Algorithm

1. Confirm adherence and exclude secondary causes
2. Check labs: Creatinine, eGFR, potassium, sodium
3. Assess volume status: JVP, edema, orthopnea
4. If eGFR >45 mL/min/1.73 m²: Add spironolactone 25 mg daily
5. If eGFR 30-45 mL/min/1.73 m²: Consider spironolactone with close monitoring OR increase furosemide dose
6. If eGFR <30 mL/min/1.73 m²: Optimize furosemide dosing (up to 80-160 mg BID), consider alternative fourth agent 10
7. Recheck BP in 1-2 weeks, labs in 5-7 days after spironolactone initiation

Common Pitfalls to Avoid

• Don't combine ACE inhibitor with ARB: She's already on valsartan; adding an ACE inhibitor increases risk of hyperkalemia and renal dysfunction without benefit 11, 2
• Don't use non-dihydropyridine CCBs (diltiazem, verapamil) if heart failure present due to negative inotropic effects 5
• Don't use short-acting nifedipine 12
• Don't assume HCTZ 12.5 mg is adequate: This is a low dose with limited efficacy 1
• Don't overlook medication non-adherence: This is the most common cause of apparent resistant hypertension 3

Target Blood Pressure

Goal: <130/80 mmHg 5, 1. In elderly patients with wide pulse pressure, lowering systolic may cause very low diastolic (<60 mmHg); monitor for symptoms of myocardial ischemia or worsening heart failure 5.